Results 171 to 180 of about 200,923 (265)

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Protecting Against Unintended Risk From Student Quality Improvement Projects in Health Care. [PDF]

Adv Health Inf Sci Pract
Bryant-Gawthrop I.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Secure bioinformatics: privacy-preserving federated analytics using homomorphic encryption. [PDF]

Bioinformatics
Zhou W, Jin C, Yao Z, Muthu Selva Annamalai MS, Chan YE, Ashish Jith SK, Deng X, Chan FM, Foong KL, Ming Hong RC, Wong KW, Sik Yin RF, Lam CSP, Richards AM, Lim WK, Yap J, Yeo KK, Patrick Tan BO, Karnani N, Krishnaswamy P, Maurer-Stroh S, Mi Aung KM.   +21 more
europepmc   +1 more source

An ambitious global goal on adaptation for heritage. [PDF]

NPJ Clim Action
Simpson N, Sabour S, Zvobgo L, Potts A, Williams PA, Clarke J, Trisos CH.   +6 more
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Congo's conflicts, minerals and microbes: planetary health implications. [PDF]

BMJ Glob Health
Ebrahim SH, Ditekemena J, Alahmad B, Duhaime AC, Mwamba D, Memish ZA.   +5 more
europepmc   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari, Caroline S. Copeland, Georgia C. Richards   +2 more
wiley   +1 more source

The analysis of competing hypotheses and expert witness testimony: Counteracting adversarial allegiance in witness credibility assessments? [PDF]

PLoS One
Otzipka J, Volbert R.
europepmc   +1 more source